Zentalis Pharmaceuticals, Inc.

ZNTL

$2.70

Name : Zentalis Pharmaceuticals, Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $255,614,160.00

EPSttm : -1.96

Zentalis Pharmaceuticals, Inc.

$2.70

1.82%

$0.05

ZNTL — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

7.13

Margin Of Safety %

Put/Call OI Ratio

0.27

EPS Next Q Diff

0.04

EPS Last/This Y

-0.2

EPS This/Next Y

0.31

Price

2.7

Target Price

7.3

Analyst Recom

1.83

Performance Q

-33.17

Upside

-1,697.0%

Beta

1.93

Ticker: ZNTL

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-08-28	ZNTL	3.8	0.07	0.77	6089
2026-08-31	ZNTL	3.77	0.08	500.00	6227
2026-09-02	ZNTL	3.77	0.13	0.00	6485
2026-09-03	ZNTL	4.11	0.13	1.91	6485
2026-09-04	ZNTL	3.99	0.13	999.99	6487
2026-09-08	ZNTL	4.04	0.13	0.05	6487
2026-09-09	ZNTL	3.8	0.13	0.50	6514
2026-09-10	ZNTL	3.6	0.13	0.50	6519
2026-09-11	ZNTL	3.51	0.13	2.33	6526
2026-09-14	ZNTL	3.51	0.13	72.00	6529
2026-09-15	ZNTL	3.12	0.15	1.85	6672
2026-09-16	ZNTL	3.09	0.15	2.00	6698
2026-09-17	ZNTL	3.08	0.15	7.33	6705
2026-09-18	ZNTL	3.1	0.15	999.99	6685
2026-09-21	ZNTL	3.04	0.16	71.57	6402
2026-09-22	ZNTL	3.08	0.19	14.46	6600
2026-09-23	ZNTL	2.85	0.23	22.00	6864
2026-09-24	ZNTL	2.74	0.26	7.95	7043
2026-09-25	ZNTL	2.7	0.27	5.80	7144
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-08-28	ZNTL	3.80	-56.0	-	-2.11
2026-08-31	ZNTL	3.76	-56.0	-	-2.11
2026-09-01	ZNTL	3.70	-56.0	-	-2.11
2026-09-02	ZNTL	3.78	-56.0	-	-2.11
2026-09-03	ZNTL	4.11	-56.0	-	-2.11
2026-09-04	ZNTL	4.00	-56.0	-	-2.11
2026-09-08	ZNTL	4.04	-56.0	-	-2.11
2026-09-10	ZNTL	3.60	-56.0	-	-2.11
2026-09-11	ZNTL	3.50	-56.0	-	-2.11
2026-09-14	ZNTL	3.50	-56.0	-	-2.11
2026-09-15	ZNTL	3.12	-56.0	-	-2.11
2026-09-16	ZNTL	3.12	-56.0	-	-2.11
2026-09-17	ZNTL	3.08	-56.0	-	-2.11
2026-09-18	ZNTL	3.09	-56.0	-	-2.11
2026-09-21	ZNTL	3.03	-56.0	-	-2.11
2026-09-22	ZNTL	3.08	-56.0	-	-2.11
2026-09-23	ZNTL	2.86	-56.0	-	-2.11
2026-09-24	ZNTL	2.74	-56.0	-	-2.11
2026-09-25	ZNTL	2.70	-56.0	-	-2.11
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-08-28	ZNTL	18.66	4.70	8.90
2026-08-31	ZNTL	18.66	4.67	8.90
2026-09-01	ZNTL	18.66	4.67	8.90
2026-09-02	ZNTL	18.66	4.67	8.90
2026-09-03	ZNTL	18.66	4.67	8.90
2026-09-04	ZNTL	18.66	4.67	8.90
2026-09-08	ZNTL	18.66	4.69	8.90
2026-09-09	ZNTL	18.66	4.69	8.90
2026-09-10	ZNTL	18.66	4.69	8.90
2026-09-11	ZNTL	18.66	4.69	7.44
2026-09-14	ZNTL	18.66	4.69	7.44
2026-09-15	ZNTL	18.66	4.69	7.44
2026-09-16	ZNTL	18.66	4.69	7.44
2026-09-17	ZNTL	18.66	4.69	7.44
2026-09-18	ZNTL	18.66	4.69	7.44
2026-09-21	ZNTL	18.66	4.69	7.44
2026-09-23	ZNTL	18.66	4.69	7.44
2026-09-24	ZNTL	18.66	4.69	7.44
2026-09-25	ZNTL	18.66	4.69	7.13
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

-0.59

Avg. EPS Est. Current Quarter

-0.58

Avg. EPS Est. Next Quarter

-0.55

Insider Transactions

18.66

Institutional Transactions

4.69

Beta

1.93

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

96.9

Max Drawdown 5-Year %

-98.8

Target Price

7.3

P/E

Forward P/E

PEG

P/S

P/B

1.35

P/Free Cash Flow

EPS

-1.96

Average EPS Est. Cur. Y

-2.11

EPS Next Y. (Est.)

-1.81

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.87

Return on Equity vs Sector %

-100

Return on Equity vs Industry %

-100

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.44

EBIT Estimation

◆ ZNTL Healthcare

$2.70

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

20/20

Pullback

13/25

Volume

7/15

Valuation

12/20

TP/AR

3/10

Options

6/10

RSI

24.5

Range 1M

2.6%

Sup Dist

0.4%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

14/25

Growth

4/30

Estimates

2/20

Inst/Vol

5/15

Options

7/10

EPS Yr

-11.5%

EPS NY

8.3%

52W%

25.9%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +170.4% upside

Quality

3/30

Valuation

16/30

Growth

3/25

Stability

6/10

LT Trend

4/5

Upside

+170.4%

Quality

ZNTL — P/E HistoricalBiotechnology

Zentalis Pharmaceuticals, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 106

Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers in the United States. It develops azenosertib, which is in a Phase 3 clinical trial for the treatment of ovarian cancer and other tumor types. The company also develops ZN-c3-001, a phase 1 study that evaluated azenosertib monotherapy in solid tumors; and MAMMOTH (ZN-c3-006) is a Phase 1/2 clinical trial of azenosertib in patients with PARP-inhibitor resistant ovarian cancer. It has licensing agreements and strategic collaborations with Recurium IP Holdings, LLC. Zentalis Pharmaceuticals, Inc. was incorporated in 2014 and is based in San Diego, California.

ZNTL

Latest News

—

Caricamento notizie per ZNTL…

stock quote shares ZNTL – Zentalis Pharmaceuticals, Inc. Stock Price stock today

news today ZNTL – Zentalis Pharmaceuticals, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch ZNTL – Zentalis Pharmaceuticals, Inc. yahoo finance google finance

stock history ZNTL – Zentalis Pharmaceuticals, Inc. invest stock market

stock prices ZNTL premarket after hours

ticker ZNTL fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: ZNTL

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y